Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined candesartan + amlodipine therapy and arterial function in hypertensive patients with type 2 diabetes
jRCT1091220034Completed
- Sponsor
- Tokyo Medical and Dental University
- Start
- Jan 2010
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of candesartan and amlodipine in hypertension (HTN) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Tokyo Medical and Dental University. Primary endpoints: High sensitive C-reactive protein, Interleukin-6 and 2 more. Started Jan 2010; status: completed.
02
Drugs
candesartanamlodipine
03
Conditions
hypertension (HTN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1091220034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220034.